Medical device maker Tandem falls as 2025 sales forecast mostly flat

Tandem Diabetes Care

27/02/2025 14:01

** Shares of medical device maker Tandem Diabetes Care TNDM.O down 24% at $25.50

** Company late on Wednesday forecast 2025 sales between $997 mln and $1.007 bln vs. analysts' average estimate of $1.004 billion, according to data compiled by LSEG

** Says "muted seasonality" and "shipping delays" led to softness in demand for co's insulin pumps towards the end of Q4 and expects salesforce disruptions -TNDM

** The 2025 outlook reflects the seasonal trends extending into Q1 - RBC Capital analysts

** "What will likely cause investor consternation is the lower-than-anticipated Q1 2025 revenue guidance and the implied ramp through the rest of the year" -Brokerage Citi

** Company sees Q1 sales to be about $219 million to $224 million compared to analysts' estimate of $221 million

** TNDM has risen 16.4% in the last 12 months

 (Reporting by Siddhi Mahatole)

 ((Siddhiprabhanjan.mahatole@thomsonreuters.com))